SEATTLE, June 30 /PRNewswire-FirstCall/ -- On Thursday, July 1, 2010, at 8:30 a.m. Eastern/2:30 p.m. Central European/5:30 a.m. Pacific Time, members of Cell Therapeutics, Inc.'s (CTI) (Nasdaq and MTA: CTIC) management team will host a conference call to provide an update on company financial and regulatory developments.
Conference Call Numbers | |
Thursday, July 1 | |
8:30 a.m. Eastern/2:30 p.m. Central European/5:30 a.m. Pacific Time | |
1-877-941-6010 (US Participants) | |
1-480-629-9772 (International) | |
Call-back numbers for post-listening available at 11:30 a.m. Eastern Time: | |
1-800-406-7325 (US Participants) | |
1 303 590 3030 (International) | |
Passcode: 4324359# | |
Live audio webcast at www.celltherapeutics.com will be available for post-listening approximately two hours after call ends. | |
Media Contact: | |
Dan Eramian | |
T: 206.272.4343 | |
C: 206.854.1200 | |
F: 206.272.4434 | |
E: deramian@ctiseattle.com | |
www.celltherapeutics.com/press_room | |
Investors Contact: | |
Ed Bell | |
T: 206.272.4345 | |
Lindsey Jesch Logan | |
T: 206.272.4347 | |
F: 206.272.4434 | |
www.celltherapeutics.com/investors | |
SOURCE Cell Therapeutics, Inc.
